Women in Science – Dr. Sujuan Ba – CRS Luncheon 2011
NFCR’s Dr. Sujuan Ba Energizes Women in Science at CRS Annual Luncheon
August 2011 –Sujuan Ba, Ph.D., Chief Operating Officer of the National Foundation for Cancer Research, was the featured speaker at the Controlled Release Society (CRS) Women in Science Forum Luncheon. Dr. Ba described her tenacious climb through the pharmaceutical and scientific fields, arriving at her current position where she oversees NFCR’s organizational strategic and tactical operations, fundraising and partnership development, and financial planning and management. Dr. Ba’s talk, entitled “Forging a Path on the Road Less Traveled By a Scientist,” included segments on her establishment of a powerful network of research centers and laboratories in the United States, Europe, and Asia – a network which has enabled NFCR Scientists to focus on critical aspects of cancer research.
Dr. Ba was selected by CRS for her innovative and collaborative approach to merging scientific thought with an entrepreneurial spirit. She encouraged the attendees to never stop learning and to continue to look for the next opportunity for growth, while outlining the key skills necessary for women to succeed in science. The talk was part of the 38th Annual Meeting & Exposition of the Controlled Release Society, held on July 30 – August 3, 2011 at the Gaylord National Hotel and Convention Center, National Harbor, Maryland. The event was sponsored by Roche.
The Controlled Release Society (CRS) is the premier society worldwide for delivery science and technology. More information on Dr. Ba can be found on their website. https://www.controlledreleasesociety.org/sujuan-ba-phd
2016 Update: Dr. Sujuan Ba continues to forge paths on the road less traveled by a scientist.
She has since been promoted to President and Chief Operating Officer at NFCR. As a woman in the executive suite as well as an entrepreneur, Dr. Ba continuously innovates. She continues to work collaboratively across cultures and countries in a tireless effort to disrupt cancer’s deadly path. When President Barack Obama announced a new cancer moonshot during his State of the Union Address January 12,2016, NFCR was already well positioned to be available to help on the international cancer research platform due to the GBM-AGILE initiative and her already established science connections in China.
